Mind-Reading tech tested during brain tumor surgery

NCT ID NCT07499479

First seen Apr 01, 2026 · Last updated Jun 20, 2026 · Updated 10 times

Summary

This study tests whether a computer can decode what a person is saying by recording brain activity during awake brain tumor surgery. Twenty adults with brain tumors near language areas will have a special graphene electrode grid placed on their brain surface for up to 2 hours while they name pictures. The goal is to see if machine learning algorithms can predict the named item from the brain signals, which could help surgeons protect language function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN TUMOR ADULT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of neurosurgery Lariboisière hospital-APHP

    Paris, Île-de-France Region, 75010, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

INBRAIN Graphene Cortical Interface (high-density graphene ECoG grid)

What this could lead to

If successful, this could lead to better ways to map and protect language areas during brain surgery, potentially improving surgical outcomes.

What could go wrong

This is a very early, small study (20 participants) focused on recording data, not treatment. The decoding may not work well enough, and results may not apply to all patients.

Conditions

The condition(s) this trial relates to.

brain cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.